Traumatic Brain Injuries Treatment Market Overview
Traumatic brain injury (TBI) occurs from a violent blow or head injury that disturb the normal functioning of the brain. Every year TBI contributes to a substantial number of death and permanent disability. Elder age population holds the largest share of global traumatic brain injuries treatment market due to increasing incidence of road accident and high rate of hospitalization and is expected to grow staidly during the forecast period. Whereas based on treatment, medication (drug) segment holds the highest share of this market. Increasing incidences of road traffic injury and the government initiatives to fund for traumatic brain injuries project will boost the traumatic brain injuries treatment market during assessment period.
Traumatic Brain Injuries Treatment market size was valued at USD 1.84 Billion in 2023. The traumatic brain injuries treatment industry is projected to grow from USD 1.99 Billion in 2024 to USD 3.54 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.42% during the forecast period (2024 - 2032)
However, high cost of treatment and devices may hamper the growth of global traumatic brain injuries treatment market during the forecast period.
The global traumatic brain injuries treatment market is dominated by many market players. The key players in the market are engaged in new launches of drug and devices to maintain the strategic collaborations to hold its market position. Recently the US FDA has approved the blood test to diagnose the traumatic brain injury.
Traumatic Brain Injuries (TBI) Treatment Market Players
The Global Traumatic brain injuries treatment market players are Neuren Pharmaceuticals Ltd., Oxygen Biotherapeutics Inc, Ischemic, Grace Laboratories LLC. Cognosci, Medicortex, Amarantus BioScience Holdings, Aldagen, TEVA Pharmaceutical Industries Ltd., NeuroScience Pharmaceuticals, Targacept, BioDirection, Inc., QuesGen Systems, Inc., BrainScope Company, Inc., Oculogica, BrainScope Company, Inc, Vasopharm GmbH, Silver Creek Pharmaceuticals Inc, Stemedica Cell Technologies Inc, Neural Analytics Inc, Banayan Biomarkers Inc, Zimmer Biomet.
Traumatic Brain Injuries Treatment Market Regional Analysis:
The market in the Americas is expected to dominate the global traumatic brain injuries treatment market during the forecast period owing to the increasing incidences of road traffic injuries and increasing hospitalization of geriatric population due to TBI. Additionally, the growing incidences of road traffic collision associated with the aging population are anticipated to boost the growth of the market in this region. Whereas North America holds the highest share of global traumatic brain injury treatment due to increasing number of TBI patients and increasing investment by government in research and development activity on diagnosis management.
The European market is expected to be the second-largest due to government funding and support of the healthcare sector coupled with the growing incidence of elderly patients, increasing incidences of road traffic collision and funding by the government for traumatic brain injury project. Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing during the assessment period owing to growing number of neurological canters and increasing incidences of road accident. The market in the Middle East & Africa is likely to account for the smallest share of this market. The market growth in this region can be attributed to increasing healthcare expenditure and developing healthcare infrastructure.
Traumatic Brain Injuries Treatment Market Segmentation:
Global traumatic brain injuries treatment market outlook is further segmented into treatment types and end-users.
Based on treatment types of the market is segmented into immediate emergency care, medications, surgery. On basis of medication global traumatic brain injuries treatment market is further sub-segmented into diuretics, anti-seizure drugs, coma-inducing drugs, anti-anxiety agent, anti-depressants, anti-psychotics, analgesic, anti-convulsant and anti-coagulants.
Based on brain surgery equipment, TBI market is further sub-segmented into removing clotted blood (hematomas), repairing skull fractures, bleeding in the brain, opening a window in the skull, rehabilitation.
On basis of end-users global TBI market is further segmented into hospitals, neurologist, rehabilitative canter treatment, independent pharmacies, and others.
Related Trending Reports-
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian